A detailed history of Driehaus Capital Management LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 1,953,424 shares of EWTX stock, worth $56.1 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
1,953,424
Previous 1,260,392 54.99%
Holding current value
$56.1 Million
Previous $22.7 Million 129.68%
% of portfolio
0.51%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.88 - $29.5 $11 Million - $20.4 Million
693,032 Added 54.99%
1,953,424 $52.1 Million
Q2 2024

Aug 14, 2024

SELL
$15.08 - $21.23 $111,999 - $157,675
-7,427 Reduced 0.59%
1,260,392 $22.7 Million
Q1 2024

May 15, 2024

BUY
$9.25 - $19.97 $8.07 Million - $17.4 Million
872,750 Added 220.91%
1,267,819 $23.1 Million
Q4 2023

Feb 14, 2024

BUY
$5.51 - $12.1 $2.18 Million - $4.78 Million
395,069 New
395,069 $4.32 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.82B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.